Helicobacter pylori is a risk factor for colonic neoplasms - PubMed (original) (raw)
. 2013 Feb;108(2):208-15.
doi: 10.1038/ajg.2012.407. Epub 2012 Dec 4.
Affiliations
- PMID: 23208272
- DOI: 10.1038/ajg.2012.407
Helicobacter pylori is a risk factor for colonic neoplasms
Amnon Sonnenberg et al. Am J Gastroenterol. 2013 Feb.
Abstract
Objectives: It has been suggested that Helicobacter pylori (H. pylori) constitutes a risk for the development of adenomatous polyps and adenocarcinoma of the colon. Our aim was to study the association between H. pylori-positive gastritis and the occurrence of any colonic neoplasm.
Methods: From a computerized database of surgical pathology reports, we selected 156,000 subjects who underwent colonoscopy and esophago-gastro-duodenoscopy with biopsy results from both procedures.
Results: Compared with normal gastric mucosa, H. pylori gastritis occurred more frequently among patients with hyperplastic polyps (OR=1.24, 95% CI: 1.18-1.30), adenomatous polyps (1.52, 1.46-1.57), advanced adenomas (1.80, 1.69-1.92), villous adenomas or adenomas with high-grade dysplasia (1.97, 1.82-2.14), and adenocarcinomas (2.35, 1.98-2.80). Similarly, the strength of the association between H. pylori-positive gastritis and colonic neoplasm increased with size and number of the adenomas. The association between H. pylori gastritis and the occurrence of colonic neoplasm was similar for different locations of the large bowel. Other gastric conditions etiologically associated with H. pylori, such as intestinal metaplasia, adenoma, lymphoma, and adenocarcinoma, were also significantly associated with an increased risk of colonic neoplasm.
Conclusions: Various forms of gastritis related to H. pylori infection confer an increased risk for colonic neoplasm. In the past, when H. pylori infection was more prevalent, its attributable risk to the occurrence of colorectal neoplasm may have been quite substantial.
Comment in
- Helicobacter pylori and colonic neoplasms.
Plummer M. Plummer M. Am J Gastroenterol. 2013 Feb;108(2):216-7. doi: 10.1038/ajg.2012.409. Am J Gastroenterol. 2013. PMID: 23381070
Similar articles
- Correlation between Helicobacter pylori-associated gastric diseases and colorectal neoplasia.
Qing Y, Wang M, Lin YM, Wu D, Zhu JY, Gao L, Liu YY, Yin TF. Qing Y, et al. World J Gastroenterol. 2016 May 14;22(18):4576-84. doi: 10.3748/wjg.v22.i18.4576. World J Gastroenterol. 2016. PMID: 27182167 Free PMC article. - Helicobacter pylori and colonic neoplasms.
Plummer M. Plummer M. Am J Gastroenterol. 2013 Feb;108(2):216-7. doi: 10.1038/ajg.2012.409. Am J Gastroenterol. 2013. PMID: 23381070 - Compartment theory in Helicobacter pylori-associated gastric carcinogenesis.
Tseng HH, Hsu PI, Chen HC, Lai KH, Lo GH, Lo CC, Chou NH, Mok KT, Chen IS, Chou NH, Yang HB, Liu L, Hsu PN. Tseng HH, et al. Anticancer Res. 2003 Jul-Aug;23(4):3223-9. Anticancer Res. 2003. PMID: 12926056 Clinical Trial. - [Helicobacter pylori and gastric cancer. The incidence of infection in personal experience].
Caputo S, Mosca F, Persi A, Ettaro G, Scaringi S, Russo G, Piazza D. Caputo S, et al. Minerva Chir. 2002 Oct;57(5):649-55. Minerva Chir. 2002. PMID: 12370666 Review. Italian. - Helicobacter pylori infection and precancerous lesions of the stomach.
Valle J, Gisbert JP. Valle J, et al. Hepatogastroenterology. 2001 Nov-Dec;48(42):1548-51. Hepatogastroenterology. 2001. PMID: 11813569 Review.
Cited by
- Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials.
Gong Y, Li Y, Sun Q. Gong Y, et al. Int J Clin Exp Med. 2015 Apr 15;8(4):6530-43. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131283 Free PMC article. - Helicobacter pylori infection with atrophic gastritis: An independent risk factor for colorectal adenomas.
Chen QF, Zhou XD, Fang DH, Zhang EG, Lin CJ, Feng XZ, Wang N, Wu JS, Wang D, Lin WH. Chen QF, et al. World J Gastroenterol. 2020 Oct 7;26(37):5682-5692. doi: 10.3748/wjg.v26.i37.5682. World J Gastroenterol. 2020. PMID: 33088161 Free PMC article. - DAC can restore expression of NALP1 to suppress tumor growth in colon cancer.
Chen C, Wang B, Sun J, Na H, Chen Z, Zhu Z, Yan L, Ren S, Zuo Y. Chen C, et al. Cell Death Dis. 2015 Jan 22;6(1):e1602. doi: 10.1038/cddis.2014.532. Cell Death Dis. 2015. PMID: 25611377 Free PMC article. - Factors Associated with Colorectal Polyps in Middle-Aged and Elderly Populations.
Loke SS, Chuah SK. Loke SS, et al. Int J Environ Res Public Health. 2022 Jun 20;19(12):7543. doi: 10.3390/ijerph19127543. Int J Environ Res Public Health. 2022. PMID: 35742789 Free PMC article. - The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis.
Xu K, Dai H, Wang S, Zhang J, Liu T. Xu K, et al. Onco Targets Ther. 2018 May 1;11:2445-2452. doi: 10.2147/OTT.S151514. eCollection 2018. Onco Targets Ther. 2018. PMID: 29760554 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous